Aptose Biosciences Inc. (APTO)
NASDAQ: APTO
· Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 4.36M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.43M |
| EPS (ttm) | -36.38 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | n/a |
| Volume | 648,213 |
| Avg. Volume (20D) | 225,970 |
| Open | 1.99 |
| Previous Close | 1.71 |
| Day's Range | 1.71 - 1.99 |
| 52-Week Range | 1.10 - 40.20 |
| Beta | 1.13 |
About APTO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APTO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APTO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-45.71%
Aptose Biosciences shares are trading lower after ...
Unlock content with
Pro Subscription
2 months ago
+26.67%
Aptose shares are trading higher after a Cohort Safety Review Committee unanimously approved escalating the TUS dose from 40 mg to 80 mg in the Phase 1/2 TUSCANY trial.
